J

JNJ

Johnson & Johnson
$253.91
Current Price
AI analysis
Read what the AI thinks of Johnson & Johnson in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app

Key figures

Dividend per share
$7.93
Yield
3.12%
EPS
$8.62
P/E
30.0
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings
After the close · Expected EPS: $3.02
Jan 26

Posts

No posts about JNJ yet.

About Johnson & Johnson

Johnson & Johnson is one of the world's largest healthcare companies. It makes money by selling prescription drugs for conditions like cancer, immune diseases and psoriasis, and by selling medical devices such as surgical tools and orthopedic implants. It is planning to spin off its hip and knee business.

Add JNJ to your watchlist

Add JNJ to your watchlist.
Scan with your iPhone camera: this page opens in the app.
  • Its AI analysis
  • Every story about it, live
  • An alert when a wallet trades it
Download on the App Store